Cws Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

Cws Financial Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $134,192 - $160,128	-2,768 Reduced 26.26%	7,774 $398,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $29,176 - $32,623	-504 Reduced 4.56%	10,542 $611,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $19,113 - $21,222	-300 Reduced 2.64%	11,046 $706,000
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $52,173 - $59,176	794 Added 7.52%	11,346 $786,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $12,326 - $14,596	-180 Reduced 1.68%	10,552 $759,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $23 - $14,138	-184 Reduced 1.69%	10,732 $763,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $14,372 - $16,755	268 Added 2.52%	10,916 $681,000
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $5,943 - $6,472	96 Added 0.91%	10,648 $712,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $949 - $1,067	16 Added 0.15%	10,552 $666,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $866 - $981	15 Added 0.14%	10,536 $654,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $6,304 - $7,370	-115 Reduced 1.08%	10,521 $619,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $523,397 - $682,724	10,636 New	10,636 $683,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cws Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cws Financial Advisors, LLC with notifications on news.